2 Biotech Stocks to Watch Under $20

Both equities are off their recent lows

Managing Editor
May 9, 2024 at 2:37 PM
facebook X logo linkedin


Biotech stocks are a tricky bunch, prone to wild moves and technical patterns that are tough to nail down. Anytime a stock in the volatile sector makes a big move, it's worth looking under the hood.

This week in Cheap Seats: Stocks Under $20 segment, we're analyzing two biotech stocks making outsized moves: G1 Therapeutics Inc (NASDAQ:GTHX) and Yield10 Bioscience, Inc. (NASDAQ:YTEN).

GTHX is up 18.4% at $5.08 at last check, although the specific catalyst behind this pop is unclear. The shares gapped 9.6% higher on May 1 after the company's earnings beat, and are now trading at their highest level in over a year. The stock has come a long way from its Oct. 9 record low of $1.08.

YTEN, meanwhile, is up 20.6% to trade at $6.14, again with no clear catalyst. The shares have been range-bound between $5 and $10 since a mid-August bear gap into penny stock territory. With the crop yield stock still below all major moving averages, investors will want to see more of a sustained push higher before circling back. 

Both GTHX and YTEN don't have a ton of contrarian opportunities, with only a few firms in coverage and both stocks' total available float sold short coming in at only 5.3% and 1.6%, respectively. With that said, the two equities are off their lows, and any more major moves should be a signal to investors to check back in.

 

Unlock Weekend Profits with Chris Prybal's Favorite Strategy Up +487.5% in 2024

With the markets going left, right, and sideways, you need to have a plan now more than ever. 

Expert Trader Chris Prybal is no stranger to volatility, and has mastered finding big stock rallies while other traders aren't looking over the weekend. Rallies that produced gains like +207% on RTX calls, +236% on MARA calls, and +238% on NET calls.

A few simple moves on Sunday at 7pm could be the “Secret Sauce” your portfolio needs to not just stay afloat, but make unprecedented gains in this turbulent market.


Don’t sit on the sidelines, beat the market with Chris Prybal's strategy. Join him now!

 

 
 
 


 
 

Rainmaker Ads CGI